https://european-biotechnology.net/wp-content/uploads/2025/05/EB225_Insight-DoubleValley_Scale-up-Strategy_tg-1030x550-1.png5501030Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2025-05-30 07:13:382025-05-30 07:13:38EU set to improve investment for biotech start-ups and scale-ups
https://european-biotechnology.net/wp-content/uploads/2025/05/NoMy-e1748430078568-1030x579-1.webp5791030Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2025-05-28 11:02:572025-05-28 11:02:57Norwegian Mycelium AS bags €1.25m to scale mycoprotein production
https://european-biotechnology.net/wp-content/uploads/2025/05/Nanopore1000_F_754527197_EzNeV1lcMHBGj3SfwrhQv27OR0CMo5Bt-e1748414774161.jpg537955Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2025-05-28 06:46:312025-05-28 06:46:31Reproducible nanopore sequencing to be commercialised from 2026
https://european-biotechnology.net/wp-content/uploads/2025/05/Mitochondria_-Boontharika.jpg5631000Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2025-05-26 11:56:162025-05-26 11:56:16New way to target mitochondrial diseases
https://european-biotechnology.net/wp-content/uploads/2025/05/Vicki-scaled-e1748162226781-1030x580-1.jpeg5801030Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2025-05-25 08:49:202025-05-25 08:49:20Biopharma transformation: leading drug discovery start-ups of 2025
